| __timestamp | Geron Corporation | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 16758000 | 7751000 |
| Thursday, January 1, 2015 | 17793000 | 10251000 |
| Friday, January 1, 2016 | 18761000 | 9575000 |
| Sunday, January 1, 2017 | 19287000 | 10912000 |
| Monday, January 1, 2018 | 18707000 | 11049000 |
| Tuesday, January 1, 2019 | 20893000 | 11646000 |
| Wednesday, January 1, 2020 | 25678000 | 13265000 |
| Friday, January 1, 2021 | 29665000 | 25805000 |
| Saturday, January 1, 2022 | 43628000 | 35182000 |
| Sunday, January 1, 2023 | 69135000 | 94999000 |
Unleashing the power of data
In the competitive landscape of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Geron Corporation and Viridian Therapeutics, Inc. have shown contrasting trends in their SG&A expenses from 2014 to 2023. Geron Corporation's SG&A costs have surged by over 300%, peaking in 2023, while Viridian Therapeutics, Inc. experienced a more dramatic increase, with expenses rising by over 1,100% in the same period. This stark difference highlights Viridian's aggressive expansion strategy compared to Geron's more conservative approach. Despite Viridian's higher costs, their strategic investments may position them for future growth. Investors should consider these trends when evaluating the companies' financial strategies and potential for long-term success. Understanding how these companies manage their SG&A expenses provides valuable insights into their operational efficiency and strategic priorities.
SG&A Efficiency Analysis: Comparing Takeda Pharmaceutical Company Limited and Geron Corporation
Selling, General, and Administrative Costs: Alnylam Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Bio-Techne Corporation and Geron Corporation
Madrigal Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Madrigal Pharmaceuticals, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Rhythm Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared
Arrowhead Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
ImmunityBio, Inc. or Geron Corporation: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? ImmunityBio, Inc. or Viridian Therapeutics, Inc.
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Geron Corporation
Operational Costs Compared: SG&A Analysis of Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Geron Corporation and Viridian Therapeutics, Inc.